Cargando…
Meta‐analysed numbers needed to treat of novel antidiabetic drugs for cardiovascular outcomes
AIMS: Absolute treatment effects—i.e. numbers needed to treat (NNTs)—of novel antidiabetic drugs for cardiovascular outcomes have not been comprehensively evaluated. We aimed to perform a meta‐analysis of digitalized individual patient outcomes to display and compare absolute treatment effects. METH...
Autores principales: | Wolff, Georg, Lin, Yingfeng, Akbulut, Cihan, Brockmeyer, Maximilian, Parco, Claudio, Hoss, Alexander, Sokolowski, Alexander, Westenfeld, Ralf, Kelm, Malte, Roden, Michael, Schlesinger, Sabrina, Kuss, Oliver |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9871670/ https://www.ncbi.nlm.nih.gov/pubmed/36337026 http://dx.doi.org/10.1002/ehf2.14213 |
Ejemplares similares
-
Absolute treatment effects for the primary outcome and all-cause mortality in the cardiovascular outcome trials of new antidiabetic drugs: a meta-analysis of digitalized individual patient data
por: Kuss, Oliver, et al.
Publicado: (2022) -
National Cardiovascular Data Registry-Acute Kidney Injury (NCDR) vs. Mehran risk models for prediction of contrast-induced nephropathy and need for dialysis after coronary angiography in a German patient cohort
por: Parco, Claudio, et al.
Publicado: (2021) -
Clinical efficacy and safety outcomes of bempedoic acid for LDL-C lowering therapy in patients at high cardiovascular risk: a systematic review and meta-analysis
por: Lin, Yingfeng, et al.
Publicado: (2022) -
No focus for Staphylococcus aureus bacteremia? Don’t swallow it! An educational report of a rare sepsis presentation
por: Wolff, Georg, et al.
Publicado: (2019) -
Knowledge of HbA1c and LDL‐C treatment goals, subjective level of disease‐related information and information needs in patients with atherosclerotic cardiovascular disease
por: Brockmeyer, Maximilian, et al.
Publicado: (2022)